Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PANOBINOSTAT: 1,820 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,820
Total FAERS Reports
517 (28.4%)
Deaths Reported
623
Hospitalizations
1,820
As Primary/Secondary Suspect
119
Life-Threatening
17
Disabilities
Feb 23, 2015
FDA Approved
Discontinued
Status

FDA Application: 205353 ·

Patent Expires: Jun 13, 2028 · First Report: 16000223 · Latest Report: 20240612

What Are the Most Common PANOBINOSTAT Side Effects?

#1 Most Reported
Diarrhoea
368 reports (20.2%)
#2 Most Reported
Plasma cell myeloma
279 reports (15.3%)
#3 Most Reported
Platelet count decreased
192 reports (10.5%)

All PANOBINOSTAT Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Diarrhoea 368 20.2% 76 124
Plasma cell myeloma 279 15.3% 170 80
Platelet count decreased 192 10.6% 72 90
Death 190 10.4% 189 17
Malignant neoplasm progression 166 9.1% 104 61
Fatigue 162 8.9% 28 46
Nausea 154 8.5% 44 63
Thrombocytopenia 141 7.8% 30 60
Off label use 112 6.2% 37 9
Vomiting 109 6.0% 20 60
Drug ineffective 105 5.8% 46 18
Pneumonia 99 5.4% 39 69
Pyrexia 98 5.4% 40 65
Anaemia 95 5.2% 39 49
White blood cell count decreased 83 4.6% 35 49
Disease progression 71 3.9% 26 3
Febrile neutropenia 61 3.4% 11 32
Malaise 61 3.4% 20 31
Neutrophil count decreased 53 2.9% 18 31
Constipation 51 2.8% 17 19

Who Reports PANOBINOSTAT Side Effects? Age & Gender Data

Gender: 49.7% female, 50.3% male. Average age: 61.8 years. Most reports from: US. View detailed demographics →

Is PANOBINOSTAT Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 1 0 1
2009 7 1 5
2010 6 0 5
2011 29 1 27
2012 14 1 12
2013 12 1 11
2014 38 6 34
2015 282 86 114
2016 231 100 106
2017 115 44 69
2018 96 22 57
2019 60 20 34
2020 64 20 30
2021 15 6 5
2022 5 1 1
2023 4 4 4
2024 1 0 1

View full timeline →

What Is PANOBINOSTAT Used For?

IndicationReports
Plasma cell myeloma 1,262
Product used for unknown indication 244
Plasma cell myeloma refractory 49
Acute myeloid leukaemia 33
Brain stem glioma 15
Plasmacytoma 14
Hodgkin's disease 13
Plasma cell leukaemia 12
Glioma 10
Graft versus host disease 10

PANOBINOSTAT vs Alternatives: Which Is Safer?

PANOBINOSTAT vs PANTOPRAZOLE PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS PANOBINOSTAT vs PANTOTHENIC ACID PANOBINOSTAT vs PAPAVERINE PANOBINOSTAT vs PARACETAMOL PANOBINOSTAT vs PARATHYROID HORMONE PANOBINOSTAT vs PARECOXIB PANOBINOSTAT vs PARICALCITOL PANOBINOSTAT vs PARITAPREVIR PANOBINOSTAT vs PAROXETINE

Official FDA Label for PANOBINOSTAT

Official prescribing information from the FDA-approved drug label.